Juan Quiles

Author PubWeight™ 29.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Corrected QT interval prolongation: a new predictor of cardiovascular risk in patients with non-ST-elevation acute coronary syndrome]. Rev Esp Cardiol 2008 2.06
2 Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003 1.56
3 [Impact of blood pressure control on the ankle-brachial index in hypertensive patients]. Med Clin (Barc) 2012 1.38
4 Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004 1.09
5 Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 2004 1.04
6 Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005 0.97
7 Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol 2010 0.95
8 Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004 0.93
9 Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 2008 0.91
10 Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol 2004 0.90
11 Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 2004 0.90
12 Pseudoaneurysm complicating aortic coarctation in a pregnant woman. Int J Cardiol 2004 0.88
13 Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens 2009 0.87
14 Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol 2004 0.85
15 A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome. Int J Cardiol 2005 0.84
16 Complete regression of cardiac non-Hodgkin lymphoma. Int J Cardiol 2006 0.84
17 Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol 2009 0.84
18 Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 2004 0.84
19 Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) 2012 0.83
20 Burden of systemic hypertension in patients admitted to cardiology hospitalization units. Am J Cardiol 2011 0.83
21 Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther 2009 0.83
22 Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol 2012 0.81
23 Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage. J Hypertens 2013 0.81
24 [Non-fluoroscopic electroanatomical mapping (CARTO system) in the ablation of atrial tachycardias]. Rev Esp Cardiol 2004 0.81
25 Anticoagulation prescription in atrial fibrillation. Expert Opin Pharmacother 2011 0.79
26 Plasma aldosterone and glomerular filtration in hypertensive patients with preserved renal function. Rev Esp Cardiol 2010 0.79
27 [Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart]. Rev Esp Cardiol 2008 0.77
28 Pathological ankle-brachial index is equivalent of advanced age in acute coronary syndromes. Eur J Clin Invest 2011 0.77
29 Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study. Rev Esp Cardiol 2008 0.76
30 Control of risk factors in and treatment of patients with coronary heart disease: the TRECE study. Rev Esp Cardiol 2009 0.76
31 Anomalous origin of circumflex coronary artery arising from proximal right coronary artery. Int J Cardiol 2005 0.75
32 [Hypertension in primary care. Are we aware of the magnitude of the problem and are we managing it properly?]. Rev Esp Cardiol 2005 0.75
33 C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina. Atherosclerosis 2008 0.75
34 Heart rate in acute heart failure, lower is not always better. Int J Cardiol 2010 0.75
35 Carotid resistive index in treated hypertensive patients: relationship with target organ damage. Blood Press 2012 0.75
36 Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol 2004 0.75
37 Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function. Int J Cardiol 2005 0.75
38 Comments on the ESC guidelines on the diagnosis and treatment of peripheral artery diseases. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed) 2012 0.75
39 [Acute myocardial dysfunction after nasal infiltration with cocaine]. Rev Esp Cardiol 2003 0.75
40 [Diagnostic accuracy of NT-proBNP compared with electrocardiography in detecting left ventricular hypertrophy of hypertensive origin]. Rev Esp Cardiol 2011 0.75
41 [What measure of carotid wall thickening is the best atherosclerotic loading score in the hypertensive patient: maximum or mean value?]. Rev Esp Cardiol 2011 0.75
42 Cardiac rupture during contrast-enhanced dobutamine stress echocardiography. Int J Cardiol 2005 0.75
43 Comments on the ESC guidelines on cardiovascular disease prevention (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed) 2012 0.75